Biogen’s litifilimab improves cutaneous lupus symptoms after one year
AI Summary- Biogen said litifilimab improved skin symptoms in cutaneous lupus patients during a mid-stage trial.
- 27.2% had clear or almost clear skin after one year, versus 19% at 24 weeks.
- The 93-adult trial enrolled patients unable to respond to or tolerate standard antimalarial medicines.